N/A N=40 Randomized Single-blind Treatment

Virtual Reality in the Operating Room

Anesthesia, Intravenous · Pain, Postoperative · Delayed Recovery From Anesthesia · Satisfaction · Relaxation Therapy

Bottom Line

View on ClinicalTrials.gov: NCT03614325 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Apr 2024

Primary outcome: Primary: Intraoperative Propofol Dose — 0.14; 0.00 mg/kg/min

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Virtual Reality Immersive Relaxation (Other)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Beth Israel Deaconess Medical Center
Primary completion: Nov 2019

Outcome Measures

Outcome	Result	p-value
PRIMARY Intraoperative Propofol Dose	0.14; 0.00	—
SECONDARY Other Intraoperative Anesthetics or Analgesics Administered	1; 2; 2; 1; 4; 2	—
SECONDARY Total Intraoperative Propofol Administered	50; 0; 223; 0; 260; 0	—
SECONDARY Length of PACU Stay	75.0; 53.0	—
SECONDARY Pain Assessed by Eleven Point Numerical Rating Scale	0; 0	—
SECONDARY Overall Patient Satisfaction	100; 92	—
SECONDARY Patient Survey: Agreement With the Following Statements (0-100)	100; 100; 100; 99; 0; 0	—
SECONDARY Hand Disability (QuickDASH)	40.9; 20.5	—
SECONDARY Difference Between Preoperative and Postoperative QuickDASH Scores	4.3; 7.9	—

Summary

This is a randomized, controlled trial designed to investigate whether the use of virtual reality immersive relaxation during hand/arm operations can allow for a relaxing operating room experience for patients while potentially reducing anesthesia requirements.

Eligibility Criteria

Inclusion Criteria

Patients undergoing upper extremity (hand, wrist, arm, and/or elbow) surgery at BIDMC under MAC

Exclusion Criteria

Age < 18
Open wounds or active infection of the face or eye area
History of seizures or other symptom linked to an epileptic condition
Patients who plan to wear hearing aids during the procedure
Patients with a pacemaker or other implanted medical device
Droplet or airborne precautions (as determined by BIDMC infection control policy)
Non-English speaking
Patients who require deep sedation
Patients who are deemed ineligible to approach by the surgeon

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03614325). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.